Back to Overview
Dr. Martin Fabry
Martin Fabry completed his bachelor’s degree in Molecular Biomedicine at the University of Bonn in 2014 and subsequently moved to the US as a visiting scientist at Cold Spring Harbor Laboratory (New York), where he worked on improving CRISPR/Cas9 technologies. In 2016, he obtained a master’s degree in Life and Medical Sciences with a focus on molecular mechanisms of immunity, before starting his PhD in Medical Sciences with Cancer Research UK at the University of Cambridge, where he studied genome organisation and stability.
After receiving his doctorate in 2020, Martin worked as a postdoctoral fellow in computational biology at the Gurdon Institute and the European Bioinformatics Institute (EBI) in Cambridge, focusing on stem cell development and the establishment of new technologies for stem cell differentiation.
Martin is a registered German and European Patent and Trademark Attorney, and became Managing Director of IP2 in early 2025.
- Life Science 100%
What more there is to say...
In his leisure time Martin likes running, hiking, diving and rowing.
What moves me
What the expert knows…
In a recently published decision (1), the German Federal Court of Justice (BGH) once again addressed the issue of the role of the knowledge of a person skilled in the art in the assessment of inventive step. This provides an opportunity to examine this question...
G 2/21: The Desaster failed
After almost two years of waiting, the Enlarged Board of Appeal published their long-awaited - some would say feared - decision G 2/21 on March 23, 2023 (1). In a nut shell: the disaster fails. But in detail: What is it about? Briefly, about the question of the...
Biting the Bullet
With around 482.2 billion U.S. dollars, Apple will be the world's most valuable brand by brand value in 2022, according to the Best Global Brands ranking. In the ranking compiled by Interbrand, Microsoft only came in second place with more than 278 billion U.S....
Back to Overview